CEO SUMMARY: Across the lab industry, next generation sequencing is taking hold as an effective and efficient testing platform. In response, payers are developing coding and payment policies that may affect the finances of clinical labs. Last month, Palmetto GBA, a Medicare contractor, issued NGS test guidelines that some experts see as an attempt to …
Palmetto GBA Issues Guidance On Billing NGS Test Panels Read More »
To access this post, you must purchase The Dark Report.